GSI Sole Supplier of Balloon Dissection Devices Following Guidant Injunction
This article was originally published in The Gray Sheet
Executive Summary
General Surgical Innovations says it will be the sole supplier of balloon dissection-based devices for minimally invasive surgery in the U.S. effective Nov. 15, the result of an April 14 injunction against rival Origin Medsystems, a subsidiary of Guidant.
You may also be interested in...
Tyco Makes Space For General Surgical Innovations Alongside USSC
Tyco International's $100 mil. stock-swap acquisition of minimally invasive balloon dissection device maker General Surgical Innovations is expected to close within the next 90 days, GSI estimates.
Tyco Makes Space For General Surgical Innovations Alongside USSC
Tyco International's $100 mil. stock-swap acquisition of minimally invasive balloon dissection device maker General Surgical Innovations is expected to close within the next 90 days, GSI estimates.
Guidant General Surgery Divestiture To USSC Represents Sales Of $40 Mil.
Guidant's general surgery business, which will be sold to Tyco Healthcare Group's U.S. Surgical division under an agreement announced July 7, generated annual revenues of about $40 mil., analysts estimate.